Educational lookup. Pick a peptide to see WADA / UKAD risk framing and strict-liability context. Not a substitute for a UKAD-aware anti-doping advisor or your team doctor.
ACE-031
WADA: Prohibited in sport
Treated as prohibited under WADA.
Listed on the Prohibited List or treated as prohibited under the S0 non-approved substances category. Strict liability applies: an adverse analytical finding does not require intent. Do not use without explicit anti-doping advice; in most cases the answer will be 'do not use'.
UK summary: Discontinued investigational compound. Acceleron Pharma stopped development of ACE-031 in 2013 after safety signals. Not a licensed UK medicine; not currently in active clinical development. Prohibited under WADA S1.2 / S4.
Replace UKAD, your team doctor, or your anti-doping advisor.
Questions for a sports-medicine clinician or UKAD-aware advisor
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
Is this compound on the current WADA Prohibited List, or does it fall under S0?
Are there licensed alternatives for the underlying issue?
If I'm prescribed a medicine that is on the Prohibited List, do I need a TUE?
What in-competition vs out-of-competition rules apply for my sport?
What contamination risk does an unlicensed peptide introduce for me?
If I am tested, what supply-chain evidence should I keep?